Featured Slider

Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for December 2024.

Our paper of the month highlights the findings of the stage 2 interim analysis from the first cycle of MND SMART, a phase 3, multi-arm, randomised, adaptive platform trial conducted across 20 centres in the UK.

Dr Giacomo Sferruzza, the new EAN Resident & Research Fellow Section (RRFS) Chair, gives an overview of the RRFS Office team, and their aims and priorities for the term ahead.

Our paper of the month for November presents the findings from two large trials comparing the safety and efficacy of evobrutinib with teriflunomide in adults with a diagnosis of relapsing MS.

Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for November 2024.

Prof. Kailash Bhatia, Professor of Clinical Neurology at the Department of Clinical and Movement Neuroscience of the Institute of Neurology, UCL, Queen Square, London, was voted in as President-Elect of the EAN at the EAN Congress 2024.

Our Paper of the Month for October is a phase 2, double-blind, randomised, placebo-controlled trial investigating the efficacy of a monoclonal antibody (Lu AG09222) that inhibits PACAP signalling.

Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for October 2024.

Due to unforeseen developments, the 11th Congress of the European Academy of Neurology has been relocated and will now be held in Helsinki on June 21-24, 2025.

eanNews Editor, Benedetta Bodini, and EAN Website Editor, Letizia Leocani, provide an update on recent activities and some insight into the philosophy behind the EAN's online presence

Our paper of the month for September updates the 2020 Lancet Commission report on the identification of risk factors for dementia, adding two more risk factors to the list.

EAN Secretary General, Prof. Antonio Toscano, introduces all members and observers of the newly composed EAN Board, following elections at the EAN Congress 2024 and subsequent appointments,.

Our paper of the month for August is a randomised controlled trial evaluating tenecteplase administered 4.5 to 24 hours after stroke onset in 516 Chinese patients.

Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for August 2024.

Prof. Elena Moro officially took on the presidency of Europe’s largest neurology society on Tuesday, 2 July, 2024, the final day of the 10th Annual Congress of the European Academy of Neurology in Helsinki, Finland.